difloxacin has been researched along with Escherichia coli Infections in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abo El-Ela, FI; El-Banna, HA; El-Gendy, AA; Radi, AM; Tohamy, MA | 1 |
| Choi, MJ; Damte, D; Gebru, E; Kim, YH; Lee, SJ; Park, SC | 1 |
| Amiridis, GS; Fragkou, IA; Fthenakis, GC; Gougoulis, DA; Mavrogianni, VS | 1 |
| Bower, RR; Chu, DT; Fernandes, PB; Jarvis, KP; Ramer, NR; Shipkowitz, N | 1 |
4 other study(ies) available for difloxacin and Escherichia coli Infections
| Article | Year |
|---|---|
Pharmacokinetics of difloxacin in healthy and E. coli-infected broiler chickens.
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Chickens; Ciprofloxacin; Escherichia coli Infections; Female; Injections, Intravenous; Male; Microbial Sensitivity Tests; Poultry Diseases | 2014 |
Mutant prevention concentration and phenotypic and molecular basis of fluoroquinolone resistance in clinical isolates and in vitro-selected mutants of Escherichia coli from dogs.
Topics: Animals; Anti-Bacterial Agents; Area Under Curve; Base Sequence; Ciprofloxacin; Dog Diseases; Dogs; Drug Resistance, Bacterial; Enrofloxacin; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation | 2012 |
Efficacy of difloxacin for the control of postpartum uterine infections of ewes.
Topics: Animals; Anti-Bacterial Agents; Antibiotic Prophylaxis; Case-Control Studies; Ciprofloxacin; Escherichia coli Infections; Female; Fluoroquinolones; Pregnancy; Puerperal Disorders; Sheep; Sheep Diseases; Uterine Diseases | 2007 |
In vivo evaluation of A-56619 (difloxacin) and A-56620: new aryl-fluoroquinolones.
Topics: Animals; Anti-Infective Agents; Bacteria; Bacterial Infections; Ciprofloxacin; Enterobacteriaceae Infections; Escherichia coli Infections; Female; Fluoroquinolones; Half-Life; Immunosuppression Therapy; Klebsiella Infections; Mice; Norfloxacin; Piperazines; Proteus Infections; Pseudomonas Infections; Pyelonephritis; Quinolines; Salmonella Infections, Animal; Staphylococcal Infections; Streptococcal Infections | 1986 |